MichaelKBrawerMD

Urology • Mercer Island, WA

Physician

Join to view full profile

Dr. Brawer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brawer's full profile

Already have an account?

Office
4555 Forest Ave SE
Mercer Island, WA 98040
Phone+1 206-719-8023

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1982 - 1986
Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1980 - 1982
David Geffen School of Medicine at UCLAClass of 1980

Certifications & Licensure

WA State Medical License 1989 - 2021

Clinical Trials

Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer Start of enrollment: 2011 Mar 01
Withdrawn
Phase 3

Publications & Presentations

PubMed

9 citations
Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer
Andreas Wibmer, Nicola L Robertson, Hedvig Hricak, Junting Zheng, Marinela Capanu
Abdominal Radiology. 2019-08-01
380 citations
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Timothy J Wilt, Karen M. Jones, Michael J. Barry, Gerald L. Andriole, Daniel J. Culkin
The New England Journal of Medicine. 2017-07-12
784 citations
Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical...
William J. Catalona, Alan W. Partin, Kevin M. Slawin, Michael K. Brawer, Robert C. Flanigan
JAMA. 1998-05-20

Press Mentions

Nanospectra Biosciences Names Michael Brawer, M.D. As Chief Medical OfficerJanuary 29th, 2019
Surgery for Early-Stage Prostate Cancer Does Not Lead to Longer Lives, Study FindsJuly 12th, 2017
Predicting Prostate Cancer AggressivenessAugust 26th, 2016
Join now to see all

Grant Support

Terazosin, Finasteride And Prognostic Markers In BPHNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
Morphometry And Immunohistochemistry Of BPHNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994